In bulk populations of EGFR-mutant NSCLC cells, RNA sequencing revealed a drug-induced increase in expression of LINE-1 elements and IFN response/antiviral response genes after TKI treatment [24]. Here, EGFR is linked to non-small cell lung carcinoma.